Semax is a research-use-only peptide designed for laboratory and academic study. This 10-mg formulation is under investigation for its potential neuroprotective and cognitive enhancement properties in controlled experimental settings. For research use only.
$40.00
Every serious peptide company prominently displays this. Example Research Use Only All products offered by Dakota Peptology are intended strictly for laboratory research purposes.
Every serious peptide company prominently displays this. Example Research Use Only All products offered by TruPeptides are intended strictly for laboratory research purposes.
‘
Semax is a synthetic derivative of D-aspartic acid methyl ester, originally developed for its potential cognitive and neuroprotective properties within academic and scientific research environments. This product is intended solely for research purposes and is not intended for therapeutic, human, or animal consumption.
Semax has been investigated in preclinical studies for its ability to modulate signaling pathways associated with cognitive enhancement, neuroplasticity, and potential benefits in neurodegenerative conditions. Due to its short half-life and rapid metabolism, research focuses primarily on its acute effects rather than sustained therapeutic outcomes.
Semax is synthesized to interact with intracellular pathways, particularly those involving cyclic AMP (cAMP) and protein kinase A (PKA), which may contribute to improvements in mental clarity, focus, and potential cognitive performance under controlled research conditions. Initial studies have suggested potential neuroprotective effects, though findings are preliminary and limited to in vitro and animal models.
This product is intended exclusively for research institutions, academic laboratories, and authorized researchers adhering to institutional protocols. It is not authorized for human or animal consumption and is subject to strict regulatory oversight. Users must comply with all applicable laws and guidelines governing the handling and use of research chemicals.
For research use only. Not for human or animal consumption.
Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–7) with an added Pro-Gly-Pro sequence for stability.
It has been studied for its neuroprotective, cognitive, and regulatory effects on the central nervous system.
The referenced study aimed to investigate how Semax influences recovery following spinal cord injury and its role in regulating cellular stress pathways.
Researchers focused on its interaction with molecular signaling mechanisms involved in neuronal survival and repair.
A spinal cord injury model was developed in mice, and Semax was administered to evaluate functional recovery and cellular response.
Analysis included behavioral testing, molecular assays, gene expression profiling, and imaging techniques to assess neuroinflammation and tissue repair.
Semax significantly improved functional recovery following spinal cord injury and reduced neuronal damage.
It was shown to decrease oxidative stress and inhibit inflammatory cell death pathways, supporting improved neurological outcomes. :contentReference[oaicite:1]{index=1}
Semax modulates key molecular pathways by interacting with the μ-opioid receptor and regulating ubiquitination processes.
It also reduces lysosomal membrane damage and oxidative stress, contributing to neuronal survival and repair mechanisms. :contentReference[oaicite:2]{index=2}
These findings highlight Semax as a significant peptide in research focused on neuroprotection, neural repair, and recovery following injury.
Its ability to regulate multiple cellular pathways makes it a key compound in studies of central nervous system resilience.
Semax demonstrated strong neuroprotective effects and improved functional outcomes in preclinical models of spinal cord injury.
These results support further investigation into its role in neurological recovery and neuroregulation.
